FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Paul Dorinsky

Research Profile

Chemicals & Drugs

Disorders

Asthma

Procedures

Devices

Metered Dose Inhalers

Concepts & Ideas

Phenomena

Co-author Network

Publications

TOP 3
David Price; Richard J Martin; Neil Barnes; Paul Dorinsky; Elliot Israel; Nicolas Roche; Alison Chisholm; Elizabeth V Hillyer; Linda Kemp; Amanda J Lee; Julie von Ziegenweidt; Gene Colice
Prescribing practices and asthma control with hydrofluoroalkane-beclomethasone and fluticasone: a real-world observational study.
Steven M Koenig; Nancy Ostrom; David S Pearlman; Kelli Waitkus-Edwards; Steven Yancey; Barbara A Prillaman; Paul Dorinsky
Deterioration in asthma control when subjects receiving fluticasone propionate/salmeterol 100/50 mcg Diskus are "stepped-down".
Steven M Koenig; John Joseph Murray; James Wolfe; Leslie Andersen; Steve Yancey; Barbara Prillaman; John Stauffer; Paul Dorinsky
Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Paul Dorinsky (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: David Price; Richard J Martin; Neil Barnes; Paul Dorinsky; Elliot Israel; Nicolas Roche; Alison Chisholm; Elizabeth V Hillyer; Linda Kemp; Amanda J Lee; Julie von Ziegenweidt; Gene Colice
Prescribing practices and asthma control with hydrofluoroalkane-beclomethasone and fluticasone: a real-world observational study.
The Journal of allergy and clinical immunology 2010;126(3):511-8.e1-10.
2008: Steven M Koenig; Nancy Ostrom; David S Pearlman; Kelli Waitkus-Edwards; Steven Yancey; Barbara A Prillaman; Paul Dorinsky
Deterioration in asthma control when subjects receiving fluticasone propionate/salmeterol 100/50 mcg Diskus are "stepped-down".
The Journal of asthma : official journal of the Association for the Care of Asthma 2008;45(8):681-7.
2008: Steven M Koenig; John Joseph Murray; James Wolfe; Leslie Andersen; Steve Yancey; Barbara Prillaman; John Stauffer; Paul Dorinsky
Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma?
Respiratory medicine 2008;102(5):665-73.
2007: Robert L Cowie; Louis-Philippe Boulet; Paul K Keith; Catherine A Scott-Wilson; Karen W House; Paul Dorinsky
Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Clinical therapeutics 2007;29(7):1390-402.
2006: Harold S Nelson; Paul Dorinsky
Safety of long-acting beta-agonists.
Annals of internal medicine 2006;145(9):706; author reply 708-10.
2006: Eugene R Bleecker; Steven W Yancey; Leslie A Baitinger; Lisa D Edwards; Michael Klotsman; Wayne H Anderson; Paul Dorinsky
Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma.
The Journal of allergy and clinical immunology 2006;118(4):809-16.
2006: Nizar N Jarjour; Susan J Wilson; Steven M Koenig; Michel Laviolette; Wendy C Moore; William B Davis; Dennis E Doherty; Qutayba Hamid; Elliott Israel; mani kavuru; Joe W Ramsdell; Donald P Tashkin; Donna S Reilly; Steven W Yancey; Lisa D Edwards; John L Stauffer; Paul Dorinsky; Ratko Djukanovic
Control of airway inflammation maintained at a lower steroid dose with 100/50 microg of fluticasone propionate/salmeterol.
The Journal of allergy and clinical immunology 2006;118(1):44-52.
2006: Bradley E Chipps; Joseph D Spahn; Christine A Sorkness; Leslie Baitinger; Laura B Sutton; Amanda Emmett; Paul Dorinsky
Variability in asthma severity in pediatric subjects with asthma previously receiving short-acting beta2-agonists.
The Journal of pediatrics 2006;148(4):517-21.
2006: Robert A Nathan; Anthony Rooklin; Lynne Schoaf; Catherine Scott; Anna Ellsworth; Karen House; Paul Dorinsky
Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Clinical therapeutics 2006;28(1):73-85.
2006: Harold S Nelson; Scott Weiss; Eugene R Bleecker; Steven W Yancey; Paul Dorinsky
The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol.
Chest 2006;129(1):15-26.
2005: Robert A Nathan; Steven W Yancey; Kelli Waitkus-Edwards; Barbara A Prillaman; John L Stauffer; Edward E Philpot; Paul Dorinsky; Harold S Nelson
Fluticasone propionate nasal spray is superior to montelukast for allergic rhinitis while neither affects overall asthma control.
Chest 2005;128(4):1910-20.
2005: Rohit Borker; Amanda Emmett; Priti Jhingran; Kathleen A Rickard; Paul Dorinsky
Determining economic feasibility of fluticasone propionate-salmeterol vs montelukast in the treatment of persistent asthma using a net benefit approach and cost-effectiveness acceptability curves.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2005;95(2):181-9.
2005: Randolph Malone; Craig LaForce; Sai Nimmagadda; Lynne Schoaf; Karen House; Anna Ellsworth; Paul Dorinsky
The safety of twice-daily treatment with fluticasone propionate and salmeterol in pediatric patients with persistent asthma.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2005;95(1):66-71.
2005: John M Weiler; Robert A Nathan; Ned T Rupp; Christopher Kalberg; Amanda Emmett; Paul Dorinsky
Effect of fluticasone/salmeterol administered via a single device on exercise-induced bronchospasm in patients with persistent asthma.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2005;94(1):65-72.
2004: Richard D O'Connor; Richard H Stanford; Courtney Crim; Steven W Yancey; Lisa Edwards; Kathleen A Rickard; Paul Dorinsky
Effect of fluticasone propionate and salmeterol in a single device, fluticasone propionate, and montelukast on overall asthma control, exacerbations, and costs.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2004;93(6):581-8.
2004: Jacqueline R Carranza Rosenzweig; Lisa Edwards; William R Lincourt; Paul Dorinsky; Richard ZuWallack
The relationship between health-related quality of life, lung function and daily symptoms in patients with persistent asthma.
Respiratory medicine 2004;98(12):1157-65.
2004: John Joseph Murray; Richard R. Rosenthal; Laura Somerville; Kathryn Blake; Karen House; Leslie Baitinger; Anna VanderMeer; Paul Dorinsky
Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2004;93(4):351-9.
2004: David S Pearlman; David Peden; John J Condemi; Steven Weinstein; Martha White; Leslie Baitinger; Catherine Scott; Shu-Yen Ho; Karen House; Paul Dorinsky
Efficacy and safety of fluticasone propionate/salmeterol HFA 134A MDI in patients with mild-to-moderate persistent asthma.
The Journal of asthma : official journal of the Association for the Care of Asthma 2004;41(8):797-806.
2004: Richard D O'Connor; Harold Nelson; Rohit Borker; Amanda Emmett; Priti Jhingran; Kathleen A Rickard; Paul Dorinsky
Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthma.
PharmacoEconomics 2004;22(12):815-25.
2003: William J Calhoun; Laura B Sutton; Amanda Emmett; Paul Dorinsky
Asthma variability in patients previously treated with beta2-agonists alone.
The Journal of allergy and clinical immunology 2003;112(6):1088-94.
2003: Harold S Nelson; James D Wolfe; Gary Gross; Leon S Greos; Leslie Baitinger; Catherine Scott; Paul Dorinsky
Efficacy and safety of fluticasone propionate 44 microg/salmeterol 21 microg administered in a hydrofluoroalkane metered-dose inhaler as an initial asthma maintenance treatment.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2003;91(3):263-9.
2003: Ketan Sheth; Jonathan A Bernstein; William R Lincourt; Kunal K Merchant; Lisa D Edwards; Courtney Crim; Paul Dorinsky
Patient perceptions of an inhaled asthma medication administered as an inhalation powder via the Diskus or as an inhalation aerosol via a metered-dose inhaler.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2003;91(1):55-60.
2003: Robert A Nathan; Paul Dorinsky; Jacqueline R Carranza Rosenzweig; Tushar Shah; Heather Edin; Barbara A Prillaman
Improved ability to perform strenuous activities after treatment with fluticasone propionate/salmeterol combination in patients with persistent asthma.
The Journal of asthma : official journal of the Association for the Care of Asthma 2003;40(7):815-22.
2003: William W Busse; Steven M Koenig; John Oppenheimer; Steven A Sahn; Steven W Yancey; Donna Reilly; Lisa D Edwards; Paul Dorinsky
Steroid-sparing effects of fluticasone propionate 100 microg and salmeterol 50 microg administered twice daily in a single product in patients previously controlled with fluticasone propionate 250 microg administered twice daily.
The Journal of allergy and clinical immunology 2003;111(1):57-65.
2002: Peter S Creticos; Katharine Knobil; Lisa D Edwards; Kathleen A Rickard; Paul Dorinsky
Loss of response to treatment with leukotriene receptor antagonists but not inhaled corticosteroids in patients over 50 years of age.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2002;88(4):401-9.
2002: David S Pearlman; Martha V White; Allen K Lieberman; Pamela J Pepsin; Christopher Kalberg; Amanda Emmett; Brian Bowers; Kathleen A Rickard; Paul Dorinsky
Fluticasone propionate/salmeterol combination compared with montelukast for the treatment of persistent asthma.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2002;88(2):227-35.
2002: Stuart W Stoloff; Kim Poinsett-Holmes; Paul Dorinsky
Combination therapy with inhaled long-acting beta2-agonists and inhaled corticosteroids: a paradigm shift in asthma management.
Pharmacotherapy 2002;22(2):212-26.
2002: Ketan Sheth; Rohit Borker; Amanda Emmett; Kathleen A Rickard; Paul Dorinsky
Cost-effectiveness comparison of salmeterol/fluticasone propionate versus montelukast in the treatment of adults with persistent asthma.
PharmacoEconomics 2002;20(13):909-18.
2001: William J Calhoun; Harold S Nelson; Robert A Nathan; Pamela J Pepsin; Christopher Kalberg; Amanda Emmett; Kathleen A Rickard; Paul Dorinsky
Comparison of fluticasone propionate-salmeterol combination therapy and montelukast in patients who are symptomatic on short-acting beta(2)-agonists alone.
American journal of respiratory and critical care medicine 2001;164(5):759-63.
2001: Paul Dorinsky; Lisa D Edwards; Steven W Yancey; Kathleen A Rickard
Use of changes in symptoms to predict changes in lung function in assessing the response to asthma therapy.
Clinical therapeutics 2001;23(5):701-14.